Citizens Jmp upgraded shares of Bradmer Pharmaceuticals (TSE:GLX – Free Report) to a strong-buy rating in a research report released on Tuesday,Zacks.com reports.
Bradmer Pharmaceuticals Price Performance
Recommended Stories
- Five stocks we like better than Bradmer Pharmaceuticals
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Insiders Are Selling These 3 Stocks—Here’s Why
- Find and Profitably Trade Stocks at 52-Week Lows
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- How to Calculate Options Profits
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
Receive News & Ratings for Bradmer Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bradmer Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
